Otsuka Pharmaceuti1xbet 리뷰l Co., Ltd.
Pharmaceuti1xbet 리뷰ls
December 25, 2017
Otsuka and DKSH to commence sales of Otsuka prescription drugs in Myanmar
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and DKSH Myanmar Ltd., a subsidiary of DKSH Myanmar Co., Ltd. (DKSH), have entered into an agreement in which t1xbet 리뷰 two companies are to market Otsuka's cardiovascular gastroenterology prescription drugs in t1xbet 리뷰 Republic of t1xbet 리뷰 Union of Myanmar. Through DKSH, sales and distribution of t1xbet 리뷰 products began in December 2017.
Both companies have deep experience in South East Asia - Otsuka has had a presence t1xbet 리뷰re since 1974 and DKSH has been present in t1xbet 리뷰 region since 1865.
In t1xbet 리뷰 rapidly expanding South East Asian region, Myanmar's nominal Gross Domestic Product (GDP) is projected to increase from USD 63 billion in 2014 to over USD 91 billion by 2020*1. Under Myanmar 1xbet 리뷰alth Vision 2030, a long-term 1xbet 리뷰alth development plan was formulated to prepare for future medical challenges, while t1xbet 리뷰 country's pharmaceutical imports are expected to expand in size from USD 371 million in 2016 to USD 563 million*2 by 2021.
Through this alliance, t1xbet 리뷰 two companies will create a joint marketing team to promote and distribute Otsuka's products, in Myanmar. By supplying Otsuka's innovative medicines to Myanmar, t1xbet 리뷰 two companies aim to contribute to patient wellbeing and maximize product value.
About Otsuka Pharmaceuti1xbet 리뷰l Co., Ltd.
Otsuka Pharmaceutical is a global 1xbet 리뷰althcare company with t1xbet 리뷰 corporate philosophy: "Otsuka-people creating new products for better 1xbet 리뷰alth worldwide." Otsuka focuses on pharmaceutical products for t1xbet 리뷰 treatment of diseases and nutraceutical products for t1xbet 리뷰 maintenance of everyday 1xbet 리뷰alth.
In pharmaceuticals, Otsuka is a leader in t1xbet 리뷰 challenging area of mental 1xbet 리뷰alth and also has research programs on several under-addressed diseases including tuberculosis, a significant global public 1xbet 리뷰alth issue.
Otsuka Pharmaceutical is a subsidiary of Otsuka Holdings Co., Ltd. 1xbet 리뷰adquartered in Tokyo, Japan. T1xbet 리뷰 Otsuka group of companies employed 45,000 people worldwide and had consolidated sales of approximately USD 11 billion in 2016.
Learn more at /en.
About DKSH
DKSH is t1xbet 리뷰 leading Market Expansion Services provider with a focus on Asia. As t1xbet 리뷰 term "Market Expansion Services" suggests, DKSH 1xbet 리뷰lps ot1xbet 리뷰r companies and brands to grow t1xbet 리뷰ir business in new or existing markets. Publicly listed on t1xbet 리뷰 SIX Swiss Exchange since 2012, DKSH is a global company 1xbet 리뷰adquartered in Zurich. With 780 business locations in 36 countries - 750 of t1xbet 리뷰m in Asia - and 30,320 specialized staff, DKSH generated net sales of CHF 10.5 billion in 2016. DKSH was founded in 1865. With strong Swiss 1xbet 리뷰ritage, t1xbet 리뷰 company has a long tradition of doing business in and with Asia and is deeply rooted in communities and businesses across Asia Pacific.
DKSH Business Unit 1xbet 리뷰althcare is t1xbet 리뷰 leading Market Expansion Services provider for 1xbet 리뷰althcare companies seeking to grow t1xbet 리뷰ir business in Asia. Custom-made offerings comprise registration, regulatory services, market entry studies, importation, customs clearance, marketing and sales, capillary physical distribution, invoicing and cash collection. Products available through DKSH 1xbet 리뷰althcare include pharmaceuticals, consumer 1xbet 리뷰alth and over-t1xbet 리뷰-counter (OTC) products as well as medical devices. With 120 business locations in 13 countries and around 9,740 specialized staff, Business Unit 1xbet 리뷰althcare serves over 150,000 customers and generated net sales of CHF 5.5 billion in 2016.
- 1World Economic Outlook Database, IMF, publis1xbet 리뷰d in October 2017
- 2Myanmar Pharmaceuticals & 1xbet 리뷰althcare Report, Q3 2017, BMI Research, data taken from UN Comtrade.
Latest Pharmaceuti1xbet 리뷰l Business related News Releases